These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 1347913)
21. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Zenke M; Muñoz A; Sap J; Vennström B; Beug H Cell; 1990 Jun; 61(6):1035-49. PubMed ID: 1972036 [TBL] [Abstract][Full Text] [Related]
22. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus. Rascle A; Ferrand N; Gandrillon O; Samarut J Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of proliferation and expression of T1 and cyclin D1 genes by thyroid hormone in mammary epithelial cells. González-Sancho JM; Figueroa A; López-Barahona M; López E; Beug H; Muñoz A Mol Carcinog; 2002 May; 34(1):25-34. PubMed ID: 12112320 [TBL] [Abstract][Full Text] [Related]
24. Unliganded c-erbA/thyroid hormone receptor induces trkB expression in neuroblastoma cells. Pastor R; Bernal J; Rodríguez-Peña A Oncogene; 1994 Apr; 9(4):1081-9. PubMed ID: 8134111 [TBL] [Abstract][Full Text] [Related]
25. Retinoid X receptor and c-cerbA/thyroid hormone receptor regulate erythroid cell growth and differentiation. Bartůnĕk P; Zenke M Mol Endocrinol; 1998 Sep; 12(9):1269-79. PubMed ID: 9731697 [TBL] [Abstract][Full Text] [Related]
26. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites. Wahlström GM; Harbers M; Vennström B Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306 [TBL] [Abstract][Full Text] [Related]
28. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes. Nagl SB; Nelson CC; Romaniuk PJ; Allison LA Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030 [TBL] [Abstract][Full Text] [Related]
29. Retinoic acid receptor alpha suppresses polyomavirus transformation and c-fos expression in rat fibroblasts. Talmage DA; Lackey RS Oncogene; 1992 Sep; 7(9):1837-45. PubMed ID: 1380150 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of thyroid hormone receptor alpha 1 during zebrafish embryogenesis disrupts hindbrain patterning and implicates retinoic acid receptors in the control of hox gene expression. Essner JJ; Johnson RG; Hackett PB Differentiation; 1999 Jul; 65(1):1-11. PubMed ID: 10448709 [TBL] [Abstract][Full Text] [Related]
31. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis. von Lindern M; Deiner EM; Dolznig H; Parren-Van Amelsvoort M; Hayman MJ; Mullner EW; Beug H Oncogene; 2001 Jun; 20(28):3651-64. PubMed ID: 11439328 [TBL] [Abstract][Full Text] [Related]
32. v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII. Disela C; Glineur C; Bugge T; Sap J; Stengl G; Dodgson J; Stunnenberg H; Beug H; Zenke M Genes Dev; 1991 Nov; 5(11):2033-47. PubMed ID: 1682217 [TBL] [Abstract][Full Text] [Related]
33. The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors. Schroeder C; Raynoschek C; Fuhrmann U; Damm K; Vennström B; Beug H Oncogene; 1990 Oct; 5(10):1445-53. PubMed ID: 1979159 [TBL] [Abstract][Full Text] [Related]
34. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of c-erbA proto-oncogene enhances myogenic differentiation. Carnac G; Albagli-Curiel O; Desclozeaux M; Vandromme M; Glineur C; Bègue A; Laudet V; Bonnieu A Oncogene; 1993 Nov; 8(11):3103-10. PubMed ID: 8414512 [TBL] [Abstract][Full Text] [Related]
37. Dimerization of v-erbA on inverted repeats. Zubkova I; Subauste JS Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736 [TBL] [Abstract][Full Text] [Related]
38. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer. Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012 [TBL] [Abstract][Full Text] [Related]
39. A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. Forman BM; Yang CR; Au M; Casanova J; Ghysdael J; Samuels HH Mol Endocrinol; 1989 Oct; 3(10):1610-26. PubMed ID: 2558297 [TBL] [Abstract][Full Text] [Related]
40. Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR. Barettino D; Bugge TH; Bartunek P; Vivanco Ruiz MD; Sonntag-Buck V; Beug H; Zenke M; Stunnenberg HG EMBO J; 1993 Apr; 12(4):1343-54. PubMed ID: 8096810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]